BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 19785825)

  • 1. [The depression epidemic does not exist].
    van der Feltz-Cornelis CM
    Ned Tijdschr Geneeskd; 2009; 153():A494. PubMed ID: 19785825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of neuroleptics on depressive symptoms].
    Tabeze JP
    Encephale; 1998 Jul; 24 Spec No 1():38-41. PubMed ID: 9809254
    [No Abstract]   [Full Text] [Related]  

  • 3. [Major depression. Synthesis].
    Capdeville C
    Encephale; 2000 Nov; 26 Spec No 5():17-20. PubMed ID: 11217515
    [No Abstract]   [Full Text] [Related]  

  • 4. [Discovering depression].
    Bech P; Olsen LR
    Ugeskr Laeger; 2001 Apr; 163(14):1980-2. PubMed ID: 11307355
    [No Abstract]   [Full Text] [Related]  

  • 5. Identifying difficult-to-treat depression: differential diagnosis, subtypes, and comorbidities.
    Gaynes BN
    J Clin Psychiatry; 2009; 70 Suppl 6():10-5. PubMed ID: 19922739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treating partial responders to antidepressant treatment.
    Trivedi MH
    J Clin Psychiatry; 2009 Sep; 70(9):e31. PubMed ID: 19818237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Subclinical depression: a clinically relevant condition?].
    Cuijpers P; Smit F
    Tijdschr Psychiatr; 2008; 50(8):519-28. PubMed ID: 18688776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medicalising unhappiness: new classification of depression risks more patients being put on drug treatment from which they will not benefit.
    Dowrick C; Frances A
    BMJ; 2013 Dec; 347():f7140. PubMed ID: 24322400
    [No Abstract]   [Full Text] [Related]  

  • 9. Assessing the efficacy of desvenlafaxine for improving functioning and well-being outcome measures in patients with major depressive disorder: a pooled analysis of 9 double-blind, placebo-controlled, 8-week clinical trials.
    Soares CN; Kornstein SG; Thase ME; Jiang Q; Guico-Pabia CJ
    J Clin Psychiatry; 2009 Oct; 70(10):1365-71. PubMed ID: 19906341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneity of DSM-IV major depressive disorder as a consequence of subthreshold bipolarity.
    Zimmermann P; Brückl T; Nocon A; Pfister H; Lieb R; Wittchen HU; Holsboer F; Angst J
    Arch Gen Psychiatry; 2009 Dec; 66(12):1341-52. PubMed ID: 19996039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Confounding influence of extraneous symptoms on clinical global impression ratings for depression.
    Targum SD; Busner J; Dunn J
    J Clin Psychopharmacol; 2008 Oct; 28(5):587-9. PubMed ID: 18794667
    [No Abstract]   [Full Text] [Related]  

  • 12. Description and classification of depressive disorders. Contributions for the definition of the therapy-resistance and of therapy resistant depressions.
    Sartorius N
    Pharmakopsychiatr Neuropsychopharmakol; 1974 Mar; 7(2):76-9. PubMed ID: 4438426
    [No Abstract]   [Full Text] [Related]  

  • 13. Depression: underdiagnosed, undertreated, underappreciated.
    Sheehan DV
    Manag Care; 2004 Jun; 13(6 Suppl Depression):6-8. PubMed ID: 15293765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depression status as a confounder in the effects of antidepressants on the gestation age.
    Lan TH; Wu BJ; Chiu HJ; Hu TM; Tuan YC
    Am J Psychiatry; 2008 Mar; 165(3):399-400; author reply 400. PubMed ID: 18316436
    [No Abstract]   [Full Text] [Related]  

  • 15. Therapy resistant depressions. Methodological problems. Contributions to methodical questions and animal-experimental aspects.
    Pichot P
    Pharmakopsychiatr Neuropsychopharmakol; 1974 Mar; 7(2):80-4. PubMed ID: 4438427
    [No Abstract]   [Full Text] [Related]  

  • 16. Depression and the pitfalls of causality: implications for DSM-V.
    Pies RW
    J Affect Disord; 2009 Jul; 116(1-2):1-3. PubMed ID: 19062102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are the effects of rater training sustainable? Results from a multicenter clinical trial.
    Kobak KA; Lipsitz J; Williams JB; Engelhardt N; Jeglic E; Bellew KM
    J Clin Psychopharmacol; 2007 Oct; 27(5):534-5. PubMed ID: 17873701
    [No Abstract]   [Full Text] [Related]  

  • 18. Emerging drugs for major depressive disorder.
    Kennedy SH; Rizvi SJ
    Expert Opin Emerg Drugs; 2009 Sep; 14(3):439-53. PubMed ID: 19637989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Support for the involvement of the KCNK2 gene in major depressive disorder and response to antidepressant treatment.
    Liou YJ; Chen TJ; Tsai SJ; Yu YW; Cheng CY; Hong CJ
    Pharmacogenet Genomics; 2009 Oct; 19(10):735-41. PubMed ID: 19741570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opiate treatment in depression refractory to antidepressants and electroconvulsive therapy.
    Nyhuis PW; Gastpar M; Scherbaum N
    J Clin Psychopharmacol; 2008 Oct; 28(5):593-5. PubMed ID: 18794671
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.